Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.

Tepper SJ, Krege JH, Lombard L, Asafu-Adjei JK, Dowsett SA, Raskin J, Buchanan AS, Friedman DI.

Headache. 2019 Jun 1. doi: 10.1111/head.13544. [Epub ahead of print]

PMID:
31152441
2.

Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.

Lipton RB, Tepper SJ, Reuter U, Silberstein S, Stewart WF, Nilsen J, Leonardi DK, Desai P, Cheng S, Mikol DD, Lenz R.

Neurology. 2019 May 7;92(19):e2250-e2260. doi: 10.1212/WNL.0000000000007452. Epub 2019 Apr 17.

PMID:
30996060
3.

Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.

Tepper SJ, Diener HC, Ashina M, Brandes JL, Friedman DI, Reuter U, Cheng S, Nilsen J, Leonardi DK, Lenz RA, Mikol DD.

Neurology. 2019 May 14;92(20):e2309-e2320. doi: 10.1212/WNL.0000000000007497. Epub 2019 Apr 17.

PMID:
30996056
4.

Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.

Mansfield C, Gebben DJ, Sutphin J, Tepper SJ, Schwedt TJ, Sapra S, Shah N.

Headache. 2019 May;59(5):715-726. doi: 10.1111/head.13498. Epub 2019 Mar 12.

PMID:
30861110
5.

CGRP and headache: a brief review.

Tepper SJ.

Neurol Sci. 2019 May;40(Suppl 1):99-105. doi: 10.1007/s10072-019-03769-8. Review.

PMID:
30835001
6.

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.

Tepper SJ, Dodick DW, Schmidt PC, Kellerman DJ.

Headache. 2019 Apr;59(4):509-517. doi: 10.1111/head.13482. Epub 2019 Jan 30.

PMID:
30698272
7.

Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.

Blumenfeld AM, Tepper SJ, Robbins LD, Manack Adams A, Buse DC, Orejudos A, D Silberstein S.

J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):353-360. doi: 10.1136/jnnp-2018-319290. Epub 2019 Jan 10.

9.

Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.

Dodick DW, Tepper SJ, Lipton RB, Buse DC, Stewart WF, Bayliss M, Desai P, Sapra S, Anderson K, McInerney-Prichard E.

Headache. 2018 Oct;58(9):1358-1372. doi: 10.1111/head.13426.

PMID:
30362524
10.

Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.

Stauffer VL, Sides R, Lanteri-Minet M, Kielbasa W, Jin Y, Selzler KJ, Tepper SJ.

Patient Prefer Adherence. 2018 Sep 17;12:1785-1795. doi: 10.2147/PPA.S170636. eCollection 2018.

11.

History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.

Tepper SJ.

Headache. 2018 Nov;58 Suppl 3:238-275. doi: 10.1111/head.13379. Epub 2018 Sep 22. Review.

PMID:
30242830
12.

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.

Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA.

Cephalalgia. 2018 Sep;38(10):1622-1631. doi: 10.1177/0333102418789072. Epub 2018 Aug 7.

PMID:
30086681
13.

Cranial Neuralgias.

Tepper SJ.

Continuum (Minneap Minn). 2018 Aug;24(4, Headache):1157-1178. doi: 10.1212/CON.0000000000000637.

PMID:
30074554
14.

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.

Dodick DW, Tepper SJ, Friedman DI, Gelfand AA, Kellerman DJ, Schmidt PC.

Headache. 2018 Jul;58(7):986-992. doi: 10.1111/head.13327. Epub 2018 May 21.

15.

Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine.

Tepper SJ, Johnstone MR.

Med Devices (Auckl). 2018 May 3;11:147-156. doi: 10.2147/MDER.S130900. eCollection 2018. Review.

16.

Editorial: Understanding Menstrual Migraine.

Tepper SJ.

Headache. 2018 Apr;58(4):625. doi: 10.1111/head.13289. No abstract available.

PMID:
29611189
17.

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).

Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW.

Cephalalgia. 2018 May;38(6):1038-1048. doi: 10.1177/0333102418762525. Epub 2018 Mar 4.

18.

Menstrual Migraine and Treatment Options-A Response.

Maasumi K, Tepper SJ, Kriegler JS.

Headache. 2018 Jan;58(1):147. doi: 10.1111/head.13224. No abstract available.

PMID:
29292511
19.

The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations.

Silberstein SD, Calhoun AH, Treppendahl C, Dodick DW, Rapoport AM, Mamidi A, Vargas P, Ebert TH, Tepper SJ.

Am J Manag Care. 2017 Nov;23(17 Suppl):S326-S333.

20.

Editorial: Nutraceuticals and Occipital Nerve Blocks.

Tepper SJ.

Headache. 2017 Nov;57(10):E25. doi: 10.1111/head.12787. No abstract available.

PMID:
29124759
21.

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.

Spierings EL, Brandes JL, Kudrow DB, Weintraub J, Schmidt PC, Kellerman DJ, Tepper SJ.

Cephalalgia. 2018 Feb;38(2):215-224. doi: 10.1177/0333102417737765. Epub 2017 Oct 12.

22.

Prescribing Oxygen for Cluster Headache: A Guide for the Provider.

Tepper SJ, Duplin J, Nye B, Tepper DE.

Headache. 2017 Oct;57(9):1428-1430. doi: 10.1111/head.13180. Epub 2017 Aug 30. Review.

PMID:
28857152
23.

Editorial: The Importance of the Idiopathic Intracranial Hypertension Treatment Trial.

Tepper SJ, Friedman DI.

Headache. 2017 Sep;57(8):1301-1302. doi: 10.1111/head.13150. No abstract available.

PMID:
28850180
24.

Economics of Inhaled Oxygen Use as an Acute Therapy for Cluster Headache in the United States of America.

O'Brien M, Ford JH, Aurora SK, Govindan S, Tepper DE, Tepper SJ.

Headache. 2017 Oct;57(9):1416-1427. doi: 10.1111/head.13167. Epub 2017 Aug 26.

PMID:
28842974
25.

Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray.

Kellerman DJ, Ameri M, Tepper SJ.

Pain Manag. 2017 Nov;7(6):559-567. doi: 10.2217/pmt-2017-0036. Epub 2017 Jul 25.

26.

The SUN Also Rises.

Tepper SJ.

Headache. 2017 Jun;57(6):995-996. doi: 10.1111/head.13100. No abstract available.

PMID:
28594125
27.

New treatments for headache.

Maasumi K, Tepper SJ, Rapoport AM.

Neurol Sci. 2017 May;38(Suppl 1):145-156. doi: 10.1007/s10072-017-2910-0. Review.

PMID:
28527051
28.

Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.

Silberstein S, Winner PK, McAllister PJ, Tepper SJ, Halker R, Mahmoud RA, Siffert J.

Headache. 2017 Jun;57(6):862-876. doi: 10.1111/head.13105. Epub 2017 May 11.

PMID:
28497569
29.

Roosevelt's Headache.

Tepper SJ.

Headache. 2017 May;57(5):829. doi: 10.1111/head.13063. No abstract available.

PMID:
28444947
30.

Sphenopalatine Ganglion (SPG): Stimulation Mechanism, Safety, and Efficacy.

Tepper SJ, Caparso A.

Headache. 2017 Apr;57 Suppl 1:14-28. doi: 10.1111/head.13035. Review.

PMID:
28387016
31.

Menstrual Migraine and Treatment Options: Review.

Maasumi K, Tepper SJ, Kriegler JS.

Headache. 2017 Feb;57(2):194-208. doi: 10.1111/head.12978. Epub 2016 Dec 2. Review.

PMID:
27910087
32.

Medication-Overuse Headache: Protocols and Outcomes in 149 Consecutive Patients in a Tertiary Brazilian Headache Center.

Krymchantowski AV, Tepper SJ, Jevoux C, Valença M.

Headache. 2017 Jan;57(1):87-96. doi: 10.1111/head.12970. Epub 2016 Nov 10.

PMID:
27861826
33.

Safety and Efficacy of Occipital Nerves Stimulation for the Treatment of Chronic Migraines: Randomized, Double-blind, Controlled Single-center Experience.

Mekhail NA, Estemalik E, Azer G, Davis K, Tepper SJ.

Pain Pract. 2017 Jun;17(5):669-677. doi: 10.1111/papr.12504. Epub 2016 Oct 25.

PMID:
27779368
34.

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.

Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, Liebler EJ, Rubenstein Engel E, Tepper SJ; ACT1 Study Group.

Headache. 2016 Sep;56(8):1317-32. doi: 10.1111/head.12896.

35.

Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients.

Krymchantowski AV, Tepper SJ, Jevoux C, Valença MM.

Brain Sci. 2016 Aug 15;6(3). pii: E30. doi: 10.3390/brainsci6030030. Erratum in: Brain Sci. 2017 Mar 17;7(3):.

36.

Editorial - Acupuncture and Drug Interactions.

Tepper SJ.

Headache. 2016 Jul;56(7):1237. doi: 10.1111/head.12856. No abstract available.

PMID:
27432629
37.

TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.

Bigal ME, Dodick DW, Krymchantowski AV, VanderPluym JH, Tepper SJ, Aycardi E, Loupe PS, Ma Y, Goadsby PJ.

Neurology. 2016 Jul 5;87(1):41-8. doi: 10.1212/WNL.0000000000002801. Epub 2016 Jun 8.

38.

Long-Term Outcomes and Clinical Characteristics of Hypnic Headache Syndrome: 40 Patients Series From a Tertiary Referral Center.

Tariq N, Estemalik E, Vij B, Kriegler JS, Tepper SJ, Stillman MJ.

Headache. 2016 Apr;56(4):717-24. doi: 10.1111/head.12796. Epub 2016 Mar 26.

PMID:
27015738
39.

Patent Foramen Ovale and Migraine: Closing the Debate--A Review.

Tariq N, Tepper SJ, Kriegler JS.

Headache. 2016 Mar;56(3):462-78. doi: 10.1111/head.12779. Epub 2016 Mar 7. Review.

PMID:
26952049
40.

Antiepilepsy Drugs in Migraine Prevention: Editorial.

Tepper SJ.

Headache. 2016 Mar;56(3):601-2. doi: 10.1111/head.12780. Epub 2016 Mar 1. No abstract available.

PMID:
26926490
41.

Editorial--Indomethacin.

Tepper SJ.

Headache. 2016 Feb;56(2):421. doi: 10.1111/head.12770. Epub 2016 Feb 8. No abstract available.

PMID:
26852900
42.

Cyclic vomiting syndrome, inborn errors of metabolism, migraine variants, episodic syndromes that may be associated with migraine, and other unusual pediatric headache syndromes.

Tepper SJ.

Headache. 2016 Jan;56(1):205. doi: 10.1111/head.12751. Epub 2015 Dec 21. Review. No abstract available.

PMID:
26790854
43.

Alcohol, Tobacco, Triggers, and Headache Disorders.

Tepper SJ.

Headache. 2015 Jul-Aug;55(7):1027. No abstract available.

PMID:
26417623
44.

Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.

Maasumi K, Thompson NR, Kriegler JS, Tepper SJ.

Headache. 2015 Oct;55(9):1218-24. doi: 10.1111/head.12657. Epub 2015 Sep 18. Erratum in: Headache. 2016 Feb;56(2):449.

PMID:
26381856
45.

Nutraceutical and Other Modalities for the Treatment of Headache.

Tepper SJ.

Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1018-31. doi: 10.1212/CON.0000000000000211. Review.

PMID:
26252588
46.

Frequency of Migraine Headaches in Patients With Fibromyalgia.

Vij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M, Vincent A.

Headache. 2015 Jun;55(6):860-5. doi: 10.1111/head.12590. Epub 2015 May 21.

PMID:
25994041
47.

AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.

Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, Shin P, Siffert J.

Headache. 2015 May;55(5):621-35. doi: 10.1111/head.12583. Epub 2015 May 4.

48.
49.

Chronic migraine and medication overuse headache.

Tepper SJ.

Headache. 2014 Jul-Aug;54(7):1249-50. doi: 10.1111/head.12409. Epub 2014 Jun 10. No abstract available.

PMID:
24912551
50.

Treatment persistence and switching in triptan users: a systematic literature review.

Messali AJ, Yang M, Gillard P, Tsai K, Tepper SJ, Bloudek LM, Kori SH.

Headache. 2014 Jul-Aug;54(7):1120-30. doi: 10.1111/head.12404. Epub 2014 Jun 10. Review.

PMID:
24912394

Supplemental Content

Loading ...
Support Center